Does ENCORAFENIB Cause Electrocardiogram qt prolonged? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Electrocardiogram qt prolonged have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.5% of all adverse event reports for ENCORAFENIB.
40
Reports of Electrocardiogram qt prolonged with ENCORAFENIB
0.5%
of all ENCORAFENIB reports
2
Deaths
9
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From ENCORAFENIB?
Of the 40 reports, 2 (5.0%) resulted in death, 9 (22.5%) required hospitalization, and 5 (12.5%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENCORAFENIB. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which ENCORAFENIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN